Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study

Editor’s Choice: Primary prevention of post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole: A single-dose prophylactic actinomycin D, associated with uterine evacuation - a long retrospective cohort study Editorial: Prevention of Gestational Trophoblastic Neoplasia with Actinomycin -D at the time of evacuation: A Matter of Routine Practice or Reserve for Special Circumstances? Hosted by: David Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Elza Maria Hartmann Uberti, MD, Coordinator of the Center for Trophoblastic Diseases at Maternidade Mario Totta of Irmandade de Santa Casa de Misericórdia de Porto Alegre (ISCMPA), Brazil Neil S. Horowitz, MD, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology Mass General Brigham, Harvard Medical School, Boston, MA, United States Check out more content on the journal's homepage at

You can listen to Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study online on Radio and Podcast. Open the player on this page to stream the available audio.

Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study is an episode from Gynecologic Oncology by Health Advance.

This episode is 18:12 long.

This episode was published on Mar 3, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Gynecologic Oncology when more episodes are available from the podcast feed.